Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis

• Published in: Oncogene Vol. 41; no. 12; pp. 1780 - 1794
• Main Authors: Liao, Cheng-Gong, Liang, Xiao-Hua, Ke, Yuan, Yao, Li, Liu, Man, Liu, Ze-Kun, He, Lin, Guo, Yi-Xiao, Bian, Huijie, Chen, Zhi-Nan, Kong, Ling-Min
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 18.03.2022; Nature Publishing Group
• Subjects: 13/1; 13/44; 13/89; 14/5; 38/23; 38/77; 38/79; 38/89; 45/15; 59/5; 631/80/84; 64/60; 692/53/2422; Apoptosis; Carcinoma, Non-Small-Cell Lung - pathology; CD147 antigen; Cell Biology; Cell Line, Tumor; Demethylation; DNA methylation; DNA Methylation - genetics; Gene Expression Regulation, Neoplastic; Human Genetics; Humans; Internal Medicine; Lung cancer; Lung Neoplasms - pathology; MeCP2 protein; Medicine; Medicine & Public Health; Metastases; Metastasis; Methyl-CpG binding protein; Mixed Function Oxygenases - genetics; Mixed Function Oxygenases - metabolism; Non-small cell lung carcinoma; Oncology; Proto-Oncogene Proteins - metabolism; Smad2 protein; Small cell lung carcinoma; Sp1 protein; Therapeutic targets; Tumors
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/s41388-022-02213-0

Non-small cell lung cancer (NSCLC) is a fatal disease, and its metastatic process is poorly understood. Although aberrant methylation is involved in tumor progression, the mechanisms underlying dynamic DNA methylation remain to be elucidated. It is significant to study the molecular mechanism of NSCLC metastasis and identify new biomarkers for NSCLC early diagnosis. Here, we performed MeDIP-seq and hMeDIP-seq analyses to detect the genes regulated by dynamic DNA methylation. Comparison of the 5mC and 5hmC sites revealed that the CD147 gene underwent active demethylation in NSCLC tissues compared with normal tissues, and this demethylation upregulated CD147 expression. Significantly high levels of CD147 expression and low levels of promoter methylation were observed in NSCLC tissues. Then, we identified the CD147 promoter as a target of KLF6, MeCP2, and DNMT3A. Treatment of cells with TGF-β triggered active demethylation involving loss of KLF6/MeCP2/DNMT3A and recruitment of Sp1, Tet1, TDG, and SMAD2/3 transcription complexes. A dCas9-SunTag-DNMAT3A-sgCD147-targeted methylation system was constructed to reverse CD147 expression. The targeted methylation system downregulated CD147 expression and inhibited NSCLC proliferation and metastasis in vitro and in vivo. Accordingly, we used cfDNA to detect the levels of CD147 methylation in NSCLC tissues and found that the CD147 methylation levels exhibited an inverse relationship with tumor size, lymphatic metastasis, and TNM stage. In conclusion, this study clarified the mechanism of active demethylation of CD147 and suggested that the targeted methylation of CD147 could inhibit NSCLC invasion and metastasis, providing a highly promising therapeutic target for NSCLC.